MAQUET CARDIOPULMONARY GMBH

Manufacturer adverse-event records for MAQUET CARDIOPULMONARY GMBH come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2014–2026 · thin-book · elevated Death-code · injury-light

Death-code intensity

MAQUET CARDIOPULMONARY GMBH carries an elevated Death-code share

Death-coded event_type rows are 330 of 4,117 (8.02% · elevated tercile among 443 manufacturers). Absolute volume is thin-book.

What the Death-code reading shows for MAQUET CARDIOPULMONARY GMBH

The standout signal for MAQUET CARDIOPULMONARY GMBH is Death-code intensity: 8.02% of 4,117 reports (elevated tercile), while absolute volume is thin-book.

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 15 device types, led in this extract by Malfunction at 3,629 (88.1% of event_type total). Peak single-year volume reaches 707 reports across 11 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,117
Total Reports
330
Event-type Death
158
Injury Reports
15
Device Types

Event Types

Malfunction 3,629 (88.1%)
Death 330 (8.0%)
Injury 158 (3.8%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

3,152 (75.0%)
Required Intervention 386 (9.2%)
Death 315 (7.5%)
Other 164 (3.9%)
Life Threatening 81 (1.9%)
R 58 (1.4%)
L 27 (0.6%)
D 9 (0.2%)
O 5 (0.1%)
Hospitalization 2 (0.0%)
H 1 (0.0%)

Yearly Trend

14
2014: 2
15
2015: 3
16
2016: 1
19
2019: 331
20
2020: 461
21
2021: 707
22
2022: 563
23
2023: 694
24
2024: 642
25
2025: 619
26
2026: 94